• Mashup Score: 6

    Objective Whereas genetic susceptibility for systemic lupus erythematosus (SLE) has been well explored, the triggers for clinical disease flares remain elusive. To investigate relationships between microbiota community resilience and disease activity, we performed the first longitudinal analyses of lupus gut-microbiota communities. Methods In an observational study, taxononomic analyses,…

    Tweet Tweets with this article
    • ⚠️ New kid on the block among triggers of #flares in #lupus #nephritis 🦋 📈 Longitudinal gut #microbiota analysis 🔬 💥 #Ruminococcus gnavus bloomed during flares 🆕 Novel immunogenic #lipoglycan recognised by IgG2 🆙 specific #IgG2 ⬆️ ⬆️ in flares https://t.co/MpdETeo7iY https://t.co/dLmS0L4k8j

  • Mashup Score: 1

    Objectives The activator protein-1 (AP-1) transcription factor component c-Fos regulates chondrocyte proliferation and differentiation, but its involvement in osteoarthritis (OA) has not been functionally assessed. Methods c-Fos expression was evaluated by immunohistochemistry on articular cartilage sections from patients with OA and mice subjected to the destabilisation of the medial meniscus…

    Tweet Tweets with this article
    • c-Fos regulates chondrocyte proliferation and differentiation, and cFOS-positive chondrocytes were increased in human and murine OA cartilage. New research (humans an mice) suggests it plays a role in protecting cartilage and could be a therpeutic target https://t.co/B0tmo0AbQe https://t.co/KPrOm3Spfa

  • Mashup Score: 6

    In recent years, treat-to-target strategy and early intervention strategies with immunosuppressive agents have attempted to improve the prognosis and outcome in patients with autoimmune inflammatory rheumatic diseases. However, infectious complications due to side effects of medication remain a major concern in routine practice. In this regard, vaccine immunity and vaccination programmes are of…

    Tweet Tweets with this article
    • Do you take care of #SLE patients on #biologics? 🦋 All you wanted to know about #vaccinations💉but never dared to ask for is here in this review! 👇 🔴 pneumococcus ⚪ influenza ⚫ SARS-CoV-2 🔵 varicella zoster ⭕ tetanus 🔘 other non-live 💉 👉 https://t.co/5B2PjNmTTO https://t.co/8Pe9yYj95Y

  • Mashup Score: 0

    Objectives To develop a consensual definition for the term ‘early axial spondyloarthritis—axSpA’—and ‘early peripheral spondyloarthritis—pSpA’. Methods The ASAS (Assessment of SpondyloArthritis international Society-Spondyloarthritis EARly definition) steering committee convened an international working group (WG). Five consecutive steps were followed: (1) systematic literature review (SLR); (2)…

    Tweet Tweets with this article
    • Check out the latest recommendations: ASAS consensus definition of early axial spondyloarthritis ▶️ early axSpA: sumptoms duration <2 years ▶️ axial symptoms: cervical, thoracic, back, buttock pain or morning stiffness 🔗 https://t.co/vcab2CXJso @annamolto, @sofiaramiro82 https://t.co/mAoX4wRIAG

  • Mashup Score: 0

    Objectives Systemic sclerosis (SSc) is characterised by extensive tissue fibrosis maintained by mechanotranductive/proadhesive signalling. Drugs targeting this pathway are therefore of likely therapeutic benefit. The mechanosensitive transcriptional co-activator, yes activated protein-1 (YAP1), is activated in SSc fibroblasts. The terpenoid celastrol is a YAP1 inhibitor; however, if celastrol can…

    Tweet Tweets with this article
    • What is new on the treatment of #systemic #sclerosis? ▶️ celastrol impairs fibrotic phenotype of fibroblasts ▶️ celastrol counteracts bleomycin-induced gene expression programmes ▶️ celastrol antagonise the mechanosensitive YAP pathway 🔗 https://t.co/y499g49s6W